Optimizing current treatment of gout

被引:161
作者
Rees, Frances [1 ]
Hui, Michelle [1 ]
Doherty, Michael [1 ]
机构
[1] Univ Nottingham, Div Acad Rheumatol, City Hosp Nottingham, Nottingham NG5 1PB, England
关键词
RANDOMIZED CONTROLLED-TRIAL; URATE-LOWERING THERAPY; OF-RHEUMATOLOGY GUIDELINES; PRACTICE RESEARCH DATABASE; VITAMIN-C SUPPLEMENTATION; PLACEBO-CONTROLLED TRIAL; CHRONIC KIDNEY-DISEASE; DOUBLE-BLIND TRIAL; PLASMA URIC-ACID; ASYMPTOMATIC HYPERURICEMIA;
D O I
10.1038/nrrheum.2014.32
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gout is the most common inflammatory arthritis worldwide. Although effective treatments exist to eliminate sodium urate crystals and to 'cure' the disease, the management of gout is often suboptimal. This article reviews available treatments, recommended best practice and barriers to effective care, and how these barriers might be overcome. To optimize the management of gout, health professionals need to know not only how to treat acute attacks but also how to up-titrate urate-lowering therapy against a specific target level of serum uric acid that is below the saturation point for crystal formation. Current perspectives are changing towards much earlier use of urate-lowering therapy, even at the time of first diagnosis of gout. Holistic assessment and patient education are essential to address patient-specific risk factors and ensuring adherence to individualized therapy. Shared decision-making between a fully informed patient and practitioner greatly increases the likelihood of curing gout.
引用
收藏
页码:271 / 283
页数:13
相关论文
共 132 条
[1]   Febuxostat Hypersensitivity [J].
Abeles, Aryeh M. .
JOURNAL OF RHEUMATOLOGY, 2012, 39 (03) :659-660
[2]   DOES COLCHICINE WORK - THE RESULTS OF THE 1ST CONTROLLED-STUDY IN ACUTE GOUT [J].
AHERN, MJ ;
REID, C ;
GORDON, TP ;
MCCREDIE, M ;
BROOKS, PM ;
JONES, M .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1987, 17 (03) :301-304
[3]  
ALLOWAY JA, 1993, J RHEUMATOL, V20, P111
[4]  
ALTMAN RD, 1988, J RHEUMATOL, V15, P1422
[5]  
[Anonymous], 2009, Tomorrow's doctors: Outcomes and standards for undergraduate medical education
[6]  
[Anonymous], 1987, INVEST MED INT
[7]  
[Anonymous], OST NAT CLIN GUID CA
[8]   HYPERTRIGLYCERIDEMIA AND HYPERURICEMIA - EFFECTS OF 2 FIBRIC ACID-DERIVATIVES (BEZAFIBRATE AND FENOFIBRATE) IN A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
BASTOW, MD ;
DURRINGTON, PN ;
ISHOLA, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (03) :217-220
[9]  
Becker M., 2011 ACR ARHP ANN SC
[10]   Febuxostat compared with allopurinol in patients with hyperuricemia and gout [J].
Becker, MA ;
Schumacher, HR ;
Wortmann, RL ;
MacDonald, PA ;
Eustace, D ;
Palo, WA ;
Streit, J ;
Joseph-Ridge, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2450-2461